4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-24-005762
Chief Commercial Ofc Imm Med sold 29,390 shares at an average $3.44 ($100,994)
- Chief Commercial Ofc Imm Med acquired 132,979 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
BENZENO SHARON · Chief Commercial Ofc Imm Med
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-04 | Grant or award : show line 1 in the form | +132,979 | 356,805 | D | ||
| 2024-03-05 | Sale : show line 2 in the form | −10,746 | $3.43 | $36,859 | 346,059 | D |
| 2024-03-05 | Sale : show line 3 in the form | −18,644 | $3.44 | $64,135 | 327,415 | D |
| Open-market sales · 29,390 sh · avg $3.44 · $100,994 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-04 | Grant or award : show line 4 in the form Stock Option (right to buy) | +199,549 | 199,549 | D |
Loading xslF345X05/form4.xml…